Theravance Biopharma (NASDAQ:TBPH) reported its Q4 earnings results on Monday, February 26, 2024 at 04:05 PM. Here’s what investors need to know about the announcement. EarningsTheravance Biopharma missed estimated earnings by -13.0%, reporting an EPS of $-0.17 versus an estimate of $-0.15. Revenue was up $2.92 million from the same period last year. Past Earnings PerformanceLast quarter the company beat on EPS by $0.04 which was followed by a 5.0% increase in the share price the next day. Here’s a look at Theravance Biopharma’s past performance: To track all earnings releases for Theravance B…